Ministerstvo zdravotníctva SR - Kategorizácia liekov a úradné určenie cien liekov
|
|
|
|
|
Návrhy účastníkov konania a konania začaté z podnetu ministerstva
Filter vyhľadávania
Zoznam návrhov účastníkov konaní a konaní začatých z podnetu ministerstva
| ID návrhu | Typ návrhu | Stav návrhu | ATC | ŠÚKL- kód lieku | Príznak | Konanie začaté od | Navrhovateľ | Akcia |
|---|---|---|---|---|---|---|---|---|
| << < 3 4 5 6 7 > >> | ||||||||
| 28162 | A3 | Podaný | S01EB01 | 33228 |  |
16.3.2023 | UNIMED PHARMA, spol.s.r.o | Detaily |
| 28161 | A3 | Podaný | N05BA08 | 3216D, 3230D | |
16.3.2023 | Medreg s.r.o. | Detaily |
| 28160 | A3 | Podaný | N02AJ13 | 6684D | |
16.3.2023 | Medreg s.r.o. | Detaily |
| 28159 | A3 | Podaný | C02CA06 | 4640D, 4644D | |
16.3.2023 | Medreg s.r.o. | Detaily |
| 28158 | A3 | Podaný | J01DC02 | 15869 | |
16.3.2023 | GlaxoSmithKline Trading Services Limited | Detaily |
| 28157 | A3 | Podaný | D10AF51 | 91936 | |
16.3.2023 | GlaxoSmithKline Trading Services Limited | Detaily |
| 28155 | KON | Podaný | L04AA44 | 3293D | |
15.3.2023 | Ministerstvo zdravotníctva SR | Detaily |
| 28154 | A3 | Podaný | C08CA01 | 62569, 62568 | |
15.3.2023 | Upjohn EESV | Detaily |
| 28153 | A1E | Podaný | J01CR02 | 93709 | |
15.3.2023 | GlaxoSmithKline Trading Services Limited | Detaily |
| 28126 | A3 | Podaný | N07CA01, C09CA03  |
59465, 51633 |
|
15.3.2023 | TEVA B.V. | Detaily |
| 28152 | A3 | Podaný | G04BD04 | 13102 | |
15.3.2023 | Viatris Healthcare Limited | Detaily |
| 28151 | A3 | Podaný | N04BD02 | 9262B | |
15.3.2023 | Mylan Pharmaceuticals Limited | Detaily |
| 28146 | A3 | Podaný | J01DC02 | 7678B | |
14.3.2023 | Glenmark Pharmaceuticals s.r.o. | Detaily |
| 28150 | A3 | Podaný | V08AB02, V08CA02 | 87603, 39566 |
|
14.3.2023 | GE Healthcare AS | Detaily |
| 28149 | A3 | Podaný | L01CD01 | 47858 | |
14.3.2023 | Bristol-Myers Squibb Pharma EEIG | Detaily |
| 28147 | A3 | Podaný | L04AA27 | 7379D | |
14.3.2023 | Bausch Health Ireland Limited | Detaily |
| 28145 | A3 | Podaný | N04BD02 | 8745B | |
13.3.2023 | Glenmark Pharmaceuticals s.r.o. | Detaily |
| 28144 | A3 | Podaný | N04BC05, N03AX12 | 66876, 7636D | |
13.3.2023 | Glenmark Pharmaceuticals s.r.o. | Detaily |
| 28143 | A3 | Podaný | N06DA03 | 3242D |  |
13.3.2023 | Novartis Europharm Limited | Detaily |
| 28142 | A3 | Podaný | L01AX03 | 88984 | |
13.3.2023 | STADA Arzneimittel AG | Detaily |
| 28141 | A3 | Podaný | A10BA02 | 1959A | |
13.3.2023 | Vitabalans Oy | Detaily |
| 28140 | A3 | Podaný | C09AA02 | 68699 | |
13.3.2023 | Vitabalans Oy | Detaily |
| 28139 | A3 | Podaný | C07AB07 | 54448 | |
13.3.2023 | Vitabalans Oy | Detaily |
| 28138 | A3 | Podaný | R01AD12 | 47314 | |
13.3.2023 | GlaxoSmithKline (Ireland) Limited | Detaily |
| 28130 | A1E | Podaný | V01AA | 69204 | 10.3.2023 | ALK-Abelló A/S | Detaily | |